-
Mitochondrial Calcium Controls GPX4 Acetylation and Ferropto
2026-05-20
This study reveals how mitochondrial calcium uptake, via the MCU, regulates GPX4 acetylation and thereby modulates ferroptotic cell death. The findings uncover a mechanistic link between mitochondrial metabolism and ferroptosis resistance, with implications for tumor suppression and disease model design.
-
Reelin Signaling Enables Ketamine’s Synaptic and Behavioral
2026-05-19
The referenced study demonstrates that intact synaptic Reelin signaling via Apoer2 and Src family kinases is essential for ketamine-induced synaptic plasticity and behavioral antidepressant effects in mice. These findings clarify why nearly half of patients with treatment-resistant depression may not respond to ketamine and highlight new molecular targets for therapeutic intervention.
-
Shufeng Xingbi Therapy Restores Immune Balance in Allergic R
2026-05-19
The referenced study demonstrates that Shufeng Xingbi Therapy modulates both Th1/Th2 immune balance and gut microbiota composition in an ovalbumin-induced rat model of allergic rhinitis. These findings highlight the therapy's dual mechanism—immune regulation and microbiome modulation—providing a preclinical foundation for integrative approaches to allergic inflammation.
-
Sodium Overload Disrupts Mitochondrial Metabolism via TRPM4
2026-05-18
Qiao et al. reveal that sodium influx through TRPM4 channels impairs mitochondrial energy metabolism, triggering necrosis by the NECSO pathway. These findings clarify the mechanistic link between sodium imbalance, mitochondrial dysfunction, and cell death, with implications for apoptosis research and disease modeling.
-
Mitochondrial Calcium Regulates Ferroptosis via GPX4 Acetyla
2026-05-18
This study uncovers how mitochondrial calcium uptake, mediated by the MCU, sustains GPX4 enzymatic activity through acetylation at lysine 90, thus repressing ferroptotic cell death. The findings provide a mechanistic bridge between mitochondrial metabolism and ferroptosis regulation, offering implications for cancer and acute organ injury models.
-
Otilonium Bromide in Research: Antimuscarinic Applications &
2026-05-17
Otilonium Bromide, a high-purity antimuscarinic agent from APExBIO, empowers neuroscience and smooth muscle research with robust cholinergic pathway control. This article details advanced experimental workflows, troubleshooting strategies, and comparative insights that maximize reproducibility and translational value.
-
EPI-001: A Next-Generation Inhibitor for Androgen Receptor S
2026-05-16
Explore the advanced capabilities of EPI-001, a leading androgen receptor N-terminal domain inhibitor, in overcoming resistance in prostate and triple-negative breast cancer models. This article uniquely analyzes mechanistic insights and assay implications to inform translational research.
-
Ruxolitinib (INCB018424): Optimized Workflows in Myeloprolif
2026-05-15
Ruxolitinib (INCB018424) enables precise, reproducible inhibition of JAK-STAT signaling in translational myeloproliferative disorder research. This article details actionable protocol enhancements, robust troubleshooting strategies, and unique workflow advantages that distinguish Ruxolitinib as an indispensable tool for dissecting oncogenic JAK2 fusion protein pathways.
-
Dabigatran etexilate: Direct Thrombin Inhibitor for Anticoag
2026-05-15
Dabigatran etexilate is a potent, selective oral direct thrombin inhibitor that offers predictable anticoagulant effects without the need for routine coagulation monitoring. Its nanomolar affinity for thrombin makes it highly effective in both in vitro and in vivo research models. The compound is widely used in studies focused on stroke prevention in atrial fibrillation and the modulation of the coagulation cascade.
-
Sodium Overload Impairs Mitochondrial Function via NECSO Pat
2026-05-14
Qiao et al. reveal that sodium influx disrupts mitochondrial energy metabolism, driving necrosis through the NECSO pathway. Their mechanistic study connects TRPM4-mediated sodium entry to mitochondrial dysfunction and energy failure, with broad implications for cell death research and mitochondrial function analysis.
-
FH1 Small Molecule: Transforming iPS Cell Hepatocyte Differe
2026-05-14
FH1 small molecule enables robust maturation of iPS cell-derived hepatocytes, offering reproducible increases in albumin secretion and functional markers for liver cell research. Discover how optimized workflows and troubleshooting strategies with FH1 (Catalog No. B3700) can elevate hepatocyte-like cell cultures for advanced applications, from drug metabolism to gene therapy models.
-
Protein A/G Magnetic Beads: Precision in Protein Interaction
2026-05-13
Protein A/G Magnetic Beads streamline immunoprecipitation workflows, offering unmatched specificity for capturing antibody-antigen complexes from complex samples. Their recombinant design reduces background and enhances reproducibility, making them a superior choice for protein-protein interaction and chromatin studies.
-
Technical Guide: Angiotensin I/II (1-5) in RAS Research Work
2026-05-13
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of the renin-angiotensin system, supporting studies in blood pressure regulation and aldosterone signaling. Its use is limited to cardiovascular and renal research; it should not be applied outside these parameters due to specific solubility and biochemical constraints.
-
Geneticin (G-418 Sulfate): Advanced Selection and Antiviral
2026-05-12
Explore the dual roles of G418 Sulfate (Geneticin) as a selection antibiotic and antiviral tool. Discover new scientific perspectives linking ribosomal inhibition to cell metabolism, and gain actionable protocol guidance for genetic engineering and Dengue virus research.
-
Liproxstatin-1 HCl: Optimizing Ferroptosis Assays and Models
2026-05-12
Liproxstatin-1 HCl, a nanomolar ferroptosis inhibitor from APExBIO, empowers researchers to dissect iron-dependent cell death with exceptional selectivity in both cellular and animal models. This guide translates the latest mechanistic breakthroughs into actionable workflows and troubleshooting strategies for acute renal failure and hepatic ischemia/reperfusion injury studies.